Multidisciplinary program to reduce blood chlordecone levels in Guadeloupe
Serum Chordecone Concentration in Guadeloupean Population: Impact of a Multidisciplinary Support Program on the Reduction of the Contamination Level.
This program tests whether free blood testing plus multidisciplinary support can help adults in Guadeloupe lower their chlordecone levels.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 3000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire de la Guadeloupe Academic / other |
| Locations | 1 site (Pointe-à-Pitre, Guadeloupe) |
| Trial ID | NCT07251036 on ClinicalTrials.gov |
What this trial studies
The program invites adults in Guadeloupe to receive a standardized blood test for chlordecone and provides a multidisciplinary support pathway based on results. Blood samples are collected at participating local laboratories and analyzed by the Pasteur Institute of Guadeloupe, while biological samples are stored at the Karubiotec™ Biological Resource Center. Each participant receives their chlordecone result with a recommendation note and consenting individuals are contacted by a research assistant for a follow-up questionnaire. The referral physician explains the program, prescribes the test, and manages return of results as part of a ministerial free-testing measure.
Who should consider this trial
Good fit: Adults (18+) residing in Guadeloupe who are invited by the Regional Health Agency or who request testing via their physician, who have social security coverage and provide informed consent, are eligible.
Not a fit: People without social security coverage, those under legal protection, or individuals who refuse consent are excluded and will not receive the program's testing or follow-up services.
Why it matters
Potential benefit: If successful, participants could learn their blood chlordecone level and receive personalized advice that may reduce their exposure over time.
How similar studies have performed: Population screening programs for persistent organic pollutants have been used to inform public health guidance, but direct evidence that screening alone lowers individual contaminant levels is limited.
Eligibility criteria
Show full inclusion / exclusion criteria
* All subject overs 18 years of age residing in Guadeloupe invited to participate to the program by the Regional Health Agency or subjects who requested a test from their doctor in the framework of the ministerial measure. * Subjects who have read the information note and signed the consent to participate in the study * Subjects with social security coverage Exclusion Criteria: * Refusal to participate * Person not affiliated with a social security scheme * Person under legal protection (safeguard of justice, guardianship, curatorship, etc.
Where this trial is running
Pointe-à-Pitre, Guadeloupe
- Centre Hospitalier Universitaire de la Guadeloupe — Pointe-à-Pitre, Guadeloupe, Guadeloupe (Recruiting)
Study contacts
- Principal investigator: Jacqueline DELOUMEAUX, Doctor — CHU de la Guadeloupe
- Study coordinator: Valérie HAMONY-SOTER
- Email: valerie.soter@chu-guadeloupe.fr
- Phone: +590590934686
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.